|

ciprofol Clinical Trials

2 actively recruiting trials

Also known as: Cipepofol, HSK3486, Sishuning

Pipeline

Phase 4: 1

Top Sponsors

  • Tongji Hospital1
  • Shanghai Geriatric Medical Center1

Indications

  • Osteoarthritis, Knee and Hip1
  • Hip Fractures (ICD-10 72.01-72.2)1
  • Femoral Neck Fractures1
  • Heart Disease1
  • Thoracoscopic Surgery1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.